| Net Cash Provided by (Used in) Operating Activities |
$539,000 |
USD |
-125% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$26,950,000 |
USD |
-30044% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$15,424,000 |
USD |
|
Q3 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q4 2025 |
Q2 2026 |
| Common Stock, Shares, Issued |
3,351,526 |
shares |
0% |
Q4 2025 |
Q2 2026 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q4 2025 |
Q2 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$8,791,000 |
USD |
49% |
Q4 2025 |
Q2 2026 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$4,958,000 |
USD |
-22% |
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Gross |
$10,173,000 |
USD |
-16% |
Q2 2025 |
FY 2025 |
| Depreciation |
$159,000 |
USD |
3.2% |
Q3 2025 |
Q1 2026 |
| Payments to Acquire Property, Plant, and Equipment |
$43,000 |
USD |
-40% |
Q3 2025 |
Q1 2026 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$12,055,000 |
USD |
310% |
Q4 2025 |
Q2 2026 |
| Property, Plant and Equipment, Gross |
$19,704,000 |
USD |
-0.36% |
Q2 2025 |
FY 2025 |
| Deferred Income Tax Expense (Benefit) |
$36,000 |
USD |
|
Q3 2025 |
Q1 2026 |
| Interest Expense |
$23,255,000 |
USD |
131% |
Q2 2024 |
FY 2024 |